Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraser Clift

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|February 12, 2020
Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamideLaura Chu, Fraser Clift
CJEM|May 20, 2015
Nonalcoholic Wernicke's encephalopathyAmanda Welsh, Peter Rogers, Fraser Clift
Multiple Sclerosis and Related Disorders|September 20, 2022
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?Shane Arsenault, Rochelle Y Benoit, Fraser Clift, et al.
Multiple Sclerosis and Related Disorders|July 10, 2022
Use of natalizumab in persons with multiple sclerosis: 2022 updateSarah A Morrow, Fraser Clift, Virginia Devonshire, et al.
Contemporary Clinical Trials|March 6, 2023
Translingual neurostimulation combined with physical therapy to improve walking and balance in multiple sclerosis (NeuroMSTraLS): Study protocol for a randomized controlled trialMichelle Ploughman, Ganeswara Rao Melam, Syamala Buragadda, et al.
Archives of Physical Medicine and Rehabilitation|May 18, 2026
Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trialSarah J Donkers, Keith R Lohse, Ganeswara Rao Melam, et al.
Pharmacoeconomics - Open|September 15, 2022
Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in CanadaMoogeh Baharnoori, Virender Bhan, Fraser Clift, et al.
Clinical and Experimental Immunology|January 11, 2025
Investigating T-cell-derived extracellular vesicles as biomarkers of disease activity, axonal injury, and disability in multiple sclerosisJennifer L Zagrodnik, Stephanie N Blandford, Neva J Fudge, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 12, 2025
An Overview of Multiple Sclerosis Care in Rural and Urban Newfoundland and LabradorKathleen E Fifield, Neva J Fudge, Shane T Arsenault, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|February 12, 2020
Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamideLaura Chu, Fraser Clift
CJEM|May 20, 2015
Nonalcoholic Wernicke's encephalopathyAmanda Welsh, Peter Rogers, Fraser Clift
Multiple Sclerosis and Related Disorders|September 20, 2022
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?Shane Arsenault, Rochelle Y Benoit, Fraser Clift, et al.
Multiple Sclerosis and Related Disorders|July 10, 2022
Use of natalizumab in persons with multiple sclerosis: 2022 updateSarah A Morrow, Fraser Clift, Virginia Devonshire, et al.
Contemporary Clinical Trials|March 6, 2023
Translingual neurostimulation combined with physical therapy to improve walking and balance in multiple sclerosis (NeuroMSTraLS): Study protocol for a randomized controlled trialMichelle Ploughman, Ganeswara Rao Melam, Syamala Buragadda, et al.
Archives of Physical Medicine and Rehabilitation|May 18, 2026
Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trialSarah J Donkers, Keith R Lohse, Ganeswara Rao Melam, et al.
Pharmacoeconomics - Open|September 15, 2022
Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in CanadaMoogeh Baharnoori, Virender Bhan, Fraser Clift, et al.
Clinical and Experimental Immunology|January 11, 2025
Investigating T-cell-derived extracellular vesicles as biomarkers of disease activity, axonal injury, and disability in multiple sclerosisJennifer L Zagrodnik, Stephanie N Blandford, Neva J Fudge, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 12, 2025
An Overview of Multiple Sclerosis Care in Rural and Urban Newfoundland and LabradorKathleen E Fifield, Neva J Fudge, Shane T Arsenault, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus RecommendationsMark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Pageof 2